BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2884887)

  • 1. Role of pancreatic somatostatin in determining glucagon response to arginine and morphine.
    Klaff LJ; Taborsky GJ
    Am J Physiol; 1987 Jun; 252(6 Pt 1):E751-5. PubMed ID: 2884887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic somatostatin is a mediator of glucagon inhibition by hyperglycemia.
    Klaff LJ; Taborsky GJ
    Diabetes; 1987 May; 36(5):592-6. PubMed ID: 2883057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pancreatic noradrenaline infusion on basal and stimulated islet hormone secretion in the dog.
    Ahrén B; Taborsky GJ
    Acta Physiol Scand; 1988 Feb; 132(2):143-50. PubMed ID: 2906499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine.
    Weir GC; Samols E; Loo S; Patel YC; Gabbay KH
    Diabetes; 1979 Jan; 28(1):35-40. PubMed ID: 759249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
    Lien E; Sarantakis D
    Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin analogs inhibit somatostatin release.
    Ipp E; Rivier J; Dobbs RE; Brown M; Vale W; Unger RH
    Endocrinology; 1979 May; 104(5):1270-3. PubMed ID: 436775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.
    Greenbaum CJ; Havel PJ; Taborsky GJ; Klaff LJ
    J Clin Invest; 1991 Sep; 88(3):767-73. PubMed ID: 1679440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of pancreatic hormone secretion by somatostatin-28 and somatostatin-14 in man.
    Klaff LJ; Barron JL; Levitt NS; Ling N; Millar RP
    Acta Endocrinol (Copenh); 1983 Sep; 104(1):91-5. PubMed ID: 6137927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of epinephrine on islet hormone secretion in the dog.
    Ahrén B; Veith RC; Taborsky GJ
    Int J Pancreatol; 1988 Jul; 3(5):375-88. PubMed ID: 2902147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2 purinoceptor agonists stimulate somatostatin secretion from dog pancreas.
    Bertrand G; Gross R; Ribes G; Loubatières-Mariani MM
    Eur J Pharmacol; 1990 Jul; 182(2):369-73. PubMed ID: 1975783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine effects on the release of glucagon, insulin and somatostatin from the isolated, perfused rat pancreas.
    Johansen O; Tønnesen T; Burhol PG; Reikerås O
    Res Exp Med (Berl); 1994; 194(4):231-5. PubMed ID: 7800932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagal modulation of arginine- and glucagon-induced pancreatic somatostatin secretion.
    Seino Y; Nishi S; Imura H
    Life Sci; 1985 Aug; 37(7):651-6. PubMed ID: 2862561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate and delayed effects of D-fructose upon insulin, somatostatin, and glucagon release by the perfused rat pancreas.
    Sener A; Leclercq-Meyer V; Malaisse WJ
    Endocrine; 2004 Jun; 24(1):73-81. PubMed ID: 15249706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog.
    Buchs A; Märki F; Keller U
    Regul Pept; 1982 Aug; 4(3):117-26. PubMed ID: 6127755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of endogenous nitric oxide in vagal-cholinergic stimulation of exocrine and endocrine pancreas in dogs.
    Bilski J; Konturek JW; Konturek SJ; Domschke W
    Int J Pancreatol; 1995 Aug; 18(1):41-9. PubMed ID: 7594769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximal stimulation of pancreatic islet B-cells, and A-cell response to arginine, in dogs with longterm pancreatic acinar atrophy.
    Meister R; Berger I; Schwille PO; Gebhardt C
    Eur J Surg; 1991 May; 157(5):333-40. PubMed ID: 1678647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phentolamine prevents the somatostatin-mediated inhibition of pancreatic glucagon secretion.
    Smith PH; Woods SC; Ensinck JW; Porte D
    Metabolism; 1977 Aug; 26(8):841-5. PubMed ID: 195179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.